Emi Inagaki   Eri Arai   Shin Hatou   Tomoko Sayano   Hiroko Taniguchi   Kazuno Negishi   Yae Kanai   Yasunori Sato   Hideyuki Okano   Kazuo Tsubota   Shigeto Shimmura   
Stem cells translational medicine 11(8) 841-849 2022年6月
Pluripotent stem cell (PSC)-based cell therapies have increased steadily over the past few years, and assessing the risk of tumor formation is a high priority for clinical studies. Current in vivo tumorigenesis studies require several months and d...